Epilepsy is a common neurological disorder that affects millions of people worldwide. Characterized primarily by seizures, epilepsy can present in a variety of ways depending on the individual and the ...
A new drug candidate has shown impressive results in a mid-stage clinical trial for drug-resistant epilepsy, raising hopes for patients who continue to suffer seizures despite being on multiple ...
The unpredictable, debilitating nature of a seizure can be frightening, for both the person experiencing it and anyone watching nearby. In that moment, control often slips away as muscles stiffen, ...
Levetiracetam reduces tonic-clonic seizures by over 77% in clinical studies. Ethosuximide is highly effective for absence seizures, especially in children. Valproate remains the gold standard for ...
Please provide your email address to receive an email when new articles are posted on . No serious device- or implant-related adverse events were reported. A high degree of seizures and related ...
About 60-70% of focal epilepsy patients achieve seizure control with first-line antiseizure medications (ASMs). Lamotrigine and levetiracetam demonstrate high efficacy and tolerability for seizure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results